Novartis AG News Headlines

NVS 
$89.52
*  
0.29
0.32%
Get NVS Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading NVS now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Wider Y/Y Loss at Ariad - Analyst Blog
8/13/2013 11:55:34 AM - Zacks.com

Valeant Has No Cash In Hand But A Policy Of Aggressive Acquisition
8/13/2013 2:25:00 AM - Seeking Alpha

Q2 Earnings Beat at PDL BioPharma - Analyst Blog
8/12/2013 12:35:01 PM - Zacks.com

How Much To Develop A Drug? An Update
8/12/2013 11:33:00 AM - Seeking Alpha

Insiders Are Selling Johnson & Johnson
8/12/2013 10:55:00 AM - Seeking Alpha

Loss Widens at Omeros in Q2 - Analyst Blog
8/12/2013 10:35:58 AM - Zacks.com

Regeneron: Q2 Results And Eylea Data Support The Long-Term Thesis
8/9/2013 2:06:00 PM - Seeking Alpha

Setback for Novartis' Afinitor - Analyst Blog
8/9/2013 1:15:01 PM - Zacks.com

Wedbush Expert Declares Money For Biotech Is Still Out There
8/9/2013 11:47:00 AM - Seeking Alpha

Patterson Dental Acquires Software Company - Analyst Blog
8/7/2013 5:25:01 PM - Zacks.com

Label Expansion for Novartis' Menveo - Analyst Blog
8/5/2013 4:40:15 PM - Zacks.com

Narrower-than-Expected Loss at ImmunoGen - Analyst Blog
8/5/2013 11:40:28 AM - Zacks.com

Narrower Loss at QLT in Q2 - Analyst Blog
8/5/2013 10:08:18 AM - Zacks.com

Why Is BioCryst Pharmaceuticals At 52 Week High Levels?
8/4/2013 12:20:00 PM - Seeking Alpha

Wider-Than-Expected Loss at Momenta - Analyst Blog
8/2/2013 11:07:43 AM - Zacks.com

Earnings Miss at Incyte in Q2 - Analyst Blog
8/2/2013 10:07:41 AM - Zacks.com

Pipeline Progress at Nektar - Analyst Blog
7/31/2013 3:20:01 PM - Zacks.com

Dr. Reddy's Misses on Earnings, Revs - Analyst Blog
7/31/2013 1:46:01 PM - Zacks.com

After A Sharp Pullback, Is Allergan Pretty Enough?
7/31/2013 12:59:00 PM - Investopedia

Amgen Beats on Earnings & Revs in Q2 - Analyst Blog
7/31/2013 11:21:52 AM - Zacks.com

Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for July 31, 2013
7/30/2013 9:00:06 AM - NASDAQ.com News

Favorable Ruling for Momenta - Analyst Blog
7/29/2013 4:30:05 PM - Zacks.com

Narrower-than-Expected Loss at InterMune - Analyst Blog
7/25/2013 5:29:01 PM - Zacks.com

4 Months Post-IPO, Enanta Pharmaceuticals Carries Compelling Valuation Next To Hepatitis Peers
7/24/2013 5:34:00 PM - Seeking Alpha

GW Pharma's Sativex Filed in France - Analyst Blog
7/24/2013 5:29:04 PM - Zacks.com